Biobanking

-

SMi’s 3rd Annual Biobanking conference will aim to bring together key solution providers and potential clients affiliated with pharmaceutical companies and Biobanking institutions alike.

As researchers endeavour to develop more personalised medicines, acquiring high quality biospecimens is essential. This is reflected in the estimation that the global Biobanking market is expected to reach $183 billion as biobanks experience rapid growth.

The Biobanking event will reflect the significant change driving current development in biosample management. There will be efforts to associate value to existing biological resources and coverage of important issues experienced by those who donate, manage and expend biobank samples. Focussing on the properties of data sharing and greater involvement between biobanks, allow Biobanking 2013 to give you the most recent up to date information on Biobanking today.

Benefits

• Unique insights into building and developing a successful biobanking infrastructure
• Explore novel technologies for managing biobanks - Radio Frequency Identification (RFID)
• Promote availability and maximise value from biospecimen collections
• Investigate ways in which biobanks can contribute to stratified medicines
• Interactive platform for networking between academia and industry
• Spotlight on ground-breaking topics that expose commercial opportunities for future investments
• Highlight global regulatory, legal and ethical compliance considerations

Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

24 Jun 2013



All Upcoming Events
1 2 3 Next 
Microscopy & Microanalysis2 Aug 2015
WMIC 20152 Sep 2015
World Drug Safety Congress Europe8 Sep 2015
MSACL 2015 EU8 Sep 2015
ASHG 20156 Oct 2015
Neuroscience 201517 Oct 2015
BioData World Congress21 Oct 2015
AAPS 201525 Oct 2015
Medica 201516 Nov 2015
ASCB 201512 Dec 2015

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement